Pfizer share news, announcements and annual reports
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Pfizer Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1966 on BSE, Apr 1999 on NSE
Last close ₹3,759.80up ₹25.40 (0.68%)BSE ₹3,760.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,734.40.
29 Oct: open ₹3,749.00, high ₹3,799.00, low ₹3,732.30
52-week range of traded prices to 29 Oct 2026
₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,200 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.40
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,53757.2% delivered
Pfizer shareholder meetings
63 filed, newest first. Page 1 of 2.
Jul 2026
28 Jul · Meeting
6 Jul · Meeting
May 2026
12 May · Meeting
Jul 2025
21 Jul · Meeting
Jun 2025
29 Jun · Meeting
Aug 2024
28 Aug · Meeting
Apr 2024
Feb 2024
Jan 2024
Dec 2023
Aug 2023
18 Aug · Meeting
Jul 2023
May 2023
29 May · Meeting
Apr 2023
27 Apr · Meeting
Aug 2022
27 Aug · Meeting
Aug 2021
20 Aug · Meeting
Jul 2021
28 Jul · Meeting
Sep 2020
Aug 2020
Aug 2019
10 Aug · Meeting
Jul 2019
22 Jul · Meeting
Sep 2018
Sep 2017
Aug 2017
31 Aug · Meeting
Jul 2016
Jun 2016
Aug 2015
Jun 2015
Dec 2014
Oct 2014
20 Oct · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from October 31, 2014 to November 10, 2014 for the purpose of Annual General Meeting of the Company to be held on November 10, 2014.
Aug 2014
27 Aug · Meeting
Pursuant to Section 96 of the Companies Act, 2013 the Company had made an application to the Registrar of Companies, Maharashtra, Mumbai ('RoC') seeking an extension of time for holding its Annual General Meeting (AGM) for the financial year ended March 31, 2014. Further, the Company has informed that the RoC has granted the Company time up to December 30, 2014 to hold its AGM. The date of the AGM will be intimated in due course.
Apr 2014
25 Apr · Meeting
Oct 2013
23 Oct · Meeting
Sep 2013
Jul 2013
29 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from August 30, 2013 to September 6, 2013 (both days inclusive) for the purpose of determining the eligibility of payment of dividend. Further, the Annual General Meeting of the Company is scheduled to be held on September 06, 2013.
Sep 2012
Aug 2012